Physician profile
Joel D Ackerman
NPI 1467438010
$5,161.63
in general payments reported to CMS, 2019-2025
43 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $248 · 2021: $207 · 2022: $667 · 2023: $991 · 2024: $971 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,871 · Travel and Lodging: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,870.58 |
| Travel and Lodging | $165.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $960.67 | 2019-2024 | Senza |
| Nalu Medical, INC. | $467.71 | 2021-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $459.76 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Therapies |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $421.41 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $287.20 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $281.48 | 2022-2025 | Botox, Qulipta |
| Tersera Therapeutics LLC | $237.38 | 2019 | |
| Medtronic, INC. | $200.01 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $175.92 | 2021-2025 | Eterna, Proclaim |
| Globus Medical, INC. | $139.50 | 2025 | Senza, Vyrsa V1 |
| Spr Therapeutics, INC | $133.96 | 2022-2025 | Sprint Pns System |
| Vertos Medical, INC. | $112.34 | 2022-2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $105.03 | 2019-2024 | Ztlido |
| Si-Bone, INC. | $90.32 | 2023-2025 | |
| Arbor Pharmaceuticals, INC. | $90.26 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.